Cryo-Cell International, Inc. (CCEL) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryo-Cell International, Inc. on October 23, 2025, reporting events occurring on October 18, 2025. The filing details a material amendment to the Company's existing Credit Agreement with Susser Bank.
Key Financial Metrics and Debt Structure
The filing focuses on debt restructuring rather than operational financial performance. No revenue, profit, cash flow, or margin data is provided in this document. Key debt metrics include:
- Revolving Credit Facility (RCF): Commitment reduced to $8,000,000.
- Term Loan: Original principal amount of $8,960,000 remains.
- Interest Rates (Applicable Margin):
- Base Rate (Term Loans): 4.25%
- Base Rate (Revolving): 3.75%
- Monthly SOFR (Term Loans): 3.25%
- Monthly SOFR (Revolving): 2.75%
- Commitment Fee: 0.25% per annum.
Material Changes Versus Prior Period
Significant changes to the credit facility terms include:
- Maturity Extension: The RCF maturity date was extended from October 18, 2025, to October 18, 2027. The Term Note maturity was extended from July 18, 2032, to July 29, 2032.
- Guaranty: The Company's wholly-owned subsidiary, Celle Corp., was added as a guarantor and executed a Security Agreement.
- Rate Adjustment: Applicable margins were revised downward for both Base Rate and SOFR options compared to the previous terms.
- Limit Reduction: The revolving credit commitment was reduced from $10,000,000 to $8,000,000.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the Fifth Amendment to the Credit Agreement. The filing notes that the summary of the Amendment is qualified in its entirety by the full text of the Amendment, which will be filed as an exhibit to the Company's next annual report on Form 10-K. No specific guidance, risk factors, or unusual items regarding operations are disclosed in this filing.
Investor Verification Checklist
- Verify the full text of the Fifth Amendment to the Credit Agreement in the upcoming Form 10-K filing.
- Confirm the current outstanding balance on the RCF and Term Loan to assess immediate liquidity needs.
- Review the impact of the reduced RCF limit ($8M) on the Company's working capital strategy.
- Monitor the interest rate floors (5.5% for Base Rate, 4.5% for SOFR) to calculate minimum interest expense.